Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides

IL-37 is a cytokine that plays critical protective roles in many metabolic inflammatory diseases, and its therapeutic potential has been confirmed by exogenous IL-37 administration. However, its regulatory mechanisms remain unclear. U937 cells were treated with autophagy-modifying reagents (3-MA, ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyi Shi, Chunhui Lai, Lianyu Zhao, Mingying Zhang, Xi Liu, Shanqin Peng, Weizhong Guo, Qiuying Xu, Song Chen, Guang-xing Chen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/6457879
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555095371284480
author Xiaoyi Shi
Chunhui Lai
Lianyu Zhao
Mingying Zhang
Xi Liu
Shanqin Peng
Weizhong Guo
Qiuying Xu
Song Chen
Guang-xing Chen
author_facet Xiaoyi Shi
Chunhui Lai
Lianyu Zhao
Mingying Zhang
Xi Liu
Shanqin Peng
Weizhong Guo
Qiuying Xu
Song Chen
Guang-xing Chen
author_sort Xiaoyi Shi
collection DOAJ
description IL-37 is a cytokine that plays critical protective roles in many metabolic inflammatory diseases, and its therapeutic potential has been confirmed by exogenous IL-37 administration. However, its regulatory mechanisms remain unclear. U937 cells were treated with autophagy-modifying reagents (3-MA, chloroquine, and rapamycin) with or without LPS stimulation. Thereafter, IL-37 expression and autophagic markers (Beclin1, P62/SQSTM1, and LC3) were determined. For regulatory signal pathways, phosphorylated proteins of NF-κB (p65 and IκBα), AP-1 (c-Fos/c-Jun), and MAPK signal pathways (Erk1/2 and p38 MAPK) were quantified, and the agonists and antagonists of MAPK and NF-κB pathways were also used. Healthy human peripheral blood mononuclear cells were treated similarly to confirm our results. Four rhesus monkeys were also administered chloroquine to evaluate IL-37 induction in vivo and its bioactivity on CD4 proliferation and activation. IL-37 was upregulated by rapamycin and chloroquine in both U937 cells and human PBMCs in the presence of LPS. IL-37 was preferentially induced in autophagic cells associated with LC3 conversion. AP-1 and p65 binding motifs could be deduced in the sequence of the IL-37 promoter. Inductive IL-37 expression was accompanied with increased phosphorylated Erk1/2 and AP-1 and could be completely abolished by an Erk1/2 inhibitor or augmented by Erk1/2 agonists. In monkeys, chloroquine increased IL-37 expression, which was inversely correlated with CD4 proliferation and phosphorylated STAT3. IL-37 levels were induced by rapamycin and chloroquine through the LC3, Erk1/2, and NF-κB/AP-1 pathways. Functional IL-37 could also be induced in vivo.
format Article
id doaj-art-207fd47792584a7cb40ef31cbbe1d32c
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-207fd47792584a7cb40ef31cbbe1d32c2025-02-03T05:49:31ZengWileyJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/64578796457879Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of LipopolysaccharidesXiaoyi Shi0Chunhui Lai1Lianyu Zhao2Mingying Zhang3Xi Liu4Shanqin Peng5Weizhong Guo6Qiuying Xu7Song Chen8Guang-xing Chen9Guangzhou University of Chinese Medicine, Guangzhou 510405, ChinaScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaDivision of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaDivision of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaGuangzhou University of Chinese Medicine, Guangzhou 510405, ChinaIL-37 is a cytokine that plays critical protective roles in many metabolic inflammatory diseases, and its therapeutic potential has been confirmed by exogenous IL-37 administration. However, its regulatory mechanisms remain unclear. U937 cells were treated with autophagy-modifying reagents (3-MA, chloroquine, and rapamycin) with or without LPS stimulation. Thereafter, IL-37 expression and autophagic markers (Beclin1, P62/SQSTM1, and LC3) were determined. For regulatory signal pathways, phosphorylated proteins of NF-κB (p65 and IκBα), AP-1 (c-Fos/c-Jun), and MAPK signal pathways (Erk1/2 and p38 MAPK) were quantified, and the agonists and antagonists of MAPK and NF-κB pathways were also used. Healthy human peripheral blood mononuclear cells were treated similarly to confirm our results. Four rhesus monkeys were also administered chloroquine to evaluate IL-37 induction in vivo and its bioactivity on CD4 proliferation and activation. IL-37 was upregulated by rapamycin and chloroquine in both U937 cells and human PBMCs in the presence of LPS. IL-37 was preferentially induced in autophagic cells associated with LC3 conversion. AP-1 and p65 binding motifs could be deduced in the sequence of the IL-37 promoter. Inductive IL-37 expression was accompanied with increased phosphorylated Erk1/2 and AP-1 and could be completely abolished by an Erk1/2 inhibitor or augmented by Erk1/2 agonists. In monkeys, chloroquine increased IL-37 expression, which was inversely correlated with CD4 proliferation and phosphorylated STAT3. IL-37 levels were induced by rapamycin and chloroquine through the LC3, Erk1/2, and NF-κB/AP-1 pathways. Functional IL-37 could also be induced in vivo.http://dx.doi.org/10.1155/2020/6457879
spellingShingle Xiaoyi Shi
Chunhui Lai
Lianyu Zhao
Mingying Zhang
Xi Liu
Shanqin Peng
Weizhong Guo
Qiuying Xu
Song Chen
Guang-xing Chen
Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
Journal of Immunology Research
title Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
title_full Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
title_fullStr Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
title_full_unstemmed Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
title_short Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
title_sort chloroquine and rapamycin augment interleukin 37 expression via the lc3 erk and ap 1 axis in the presence of lipopolysaccharides
url http://dx.doi.org/10.1155/2020/6457879
work_keys_str_mv AT xiaoyishi chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT chunhuilai chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT lianyuzhao chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT mingyingzhang chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT xiliu chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT shanqinpeng chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT weizhongguo chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT qiuyingxu chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT songchen chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides
AT guangxingchen chloroquineandrapamycinaugmentinterleukin37expressionviathelc3erkandap1axisinthepresenceoflipopolysaccharides